Diabetes Clinical Trials Update 2016

Learning Objectives

  • Gauge the burden of macrovascular and microvascular disease in diabetes.
  • Understand the results and implications of recent cardiovascular outcome trials of antihyperglycemic agents.

Agenda

Click to See Video in Chapters


00:00:00
Introduction

00:03:46
What is the best add-on to metformin? Incretins vs SGLT2
Dr. Alice Cheng

00:22:29
Is there still a role for sulfonylureas in 2016?
Dr. Ronald Goldenberg

00:53:52
Clinical trial update: TECOS
Dr. Lawrence Leiter

01:16:15
DPP4 inhibitors and heart failure: final word?
Dr. Subodh Verma

01:43:48
Clinical trial update: EMPA-REG
Dr. Bernard Zinman

02:06:56
Clinical trial update: ELIXA
Dr. Stewart Harris

02:25:45
PCSK9 inhibitors in high risk patients
Dr. Lawrence Leiter

02:49:39
Diabetes and heart failure: PARADIGM-HF and beyond
Dr. Peter Liu

03:13:57
Ongoing cardiovascular trials of antihyperglycemic agents
Dr. Bernard Zinman

03:32:33
Diabetes and anti-platelet therapy: what will PARTHENON teach us?
Dr. Subodh Verma

03:54:14
RAS blockade: hypertension, nephropathy and vascular protection
Dr. David Fitchett

04:17:52
Should individuals with diabetes be treated to a more aggressive LDL target?
Dr. Robert Hegele

Chairs

Lawrence A Leiter
MD, FRCPC, FACP, FACE, FAHA
Division of Endocrinology & Metabolism,
St. Michael’s Hospital
Director, Lipid Clinic, St. Michael’s Hospital
Professor of Medicine and Nutritional Sciences,
University of Toronto

Stewart B Harris
CM, MD, MPH, FCFP, FACPM
Professor,
CDA Chair in Diabetes Management
Ian McWhinney Chair of Family Medicine Studies
Centre for Studies in Family Medicine
Schulich School of Medicine & Dentistry,
Western University

Faculty

Alice Y Y Cheng
MD, FRCPC
Division of Endocrinology & Metabolism, Credit Valley Hospital and St. Michael’s Hospital
Associate Professor of Medicine, University of Toronto

Ronald M Goldenberg
MD, FRCPC, FACE
Consultant Endocrinologist, North York Hospital and LMC Diabetes & Endocrinology

Subodh Verma
MD, PhD, FRCSC, FAHA
Division of Cardiac Surgery, St. Michael’s Hospital
Professor Surgery and Pharmacology & Toxicology, University of Toronto

Bernard Zinman
MDCM, FRCPC, FACP
Director, Leadership Sinai Centre for Diabetes, Sam and Judy Pencer Family Chair in Diabetes
Senior Scientist, Lunenfeld-Tanenbaum Research Institute
Professor of Medicine, University of Toronto

Peter P Liu
MSc, MD, FRCPC, FACC
Chief Scientific Officer / Vice President of Research, Director, Cardiac Function Laboratory, University of Ottawa Heart Institute
Professor of Medicine, University of Ottawa
Professor of Medicine, University of Toronto

David H Fitchett
MD, FRCC, FACC, FESC
Division of Cardiology, St. Michael’s Hospital
Associate Professor of Medicine, University of Toronto

Robert A Hegele
MD, FRCPC, FACP, FAHA, FCAHS
Jacob J. Wolfe Distinguished Medical Research Chair in Human Gene Function
Edith Schulich Vinet Canada Research Chair in Human Genetics
Martha Blackburn Chair in Cardiovascular Research
Distinguished University Professor of Medicine and Biochemistry, University of Western Ontario

Video Information
  • Credit:No Credit Available
  • Post Date:April 19, 2016
  • Expiry Date:N/A

Related Videos